Some U.S. Airports Begin Checking Passengers For Coronavirus

Officials report that passengers from Wuhan, China are screened at J.F.K. New York, San Francisco and Los Angeles airports for infection with coronavirus. It has killed two people and sickened at least 45 overseas. This comes from the Centers for Disease Control and Prevention.

As part of the efforts to overcome new and deadly viruses, research and developments with multidisciplinary approaches are proving vital. Leading-edge companies are working to offer new treatments that can handle the influx. Moreover, these may emerge as some of the most valuable companies in this era. Leaders that may benefit from collaborations and new approaches include Bristol-Myers Squibb Company, Oncolytics Biotech Inc, and Emergent BioSolutions Inc.

A little known company in this sector, Aethlon Medical, Inc, is a medical technology company, bringing solutions to address unmet needs in health and biodefense worldwide. Aethlon Medical Inc. (AEMD) developed the patented Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. While combating highly infectious diseases like the Ebola virus and potentially other emerging viruses, this device can be used. Aethlon is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals.

Virus Appears to Come from One Source

The news suggests that people who have contracted the infection might have derived it through exposure. Probably to animals at a specific market that sells seafood and meat in Wuhan. However, officials cannot say whether the virus spreads from person to person or how it’s being contracted.

A Good Offense Is the Best Defense

Several areas where biotechnology companies are innovating include deadly and emerging viruses. In some cases, this will also involve combing technologies or discovering new treatments. Furthermore, that’s the case with the approach taken by Aethlon Medical Inc. Unveiled in 2014, Aethlon Medical is developing its Hemopurifier®– of the most intriguing, patent-protected therapeutic devices in the world.